2009
DOI: 10.1074/jbc.m900837200
|View full text |Cite
|
Sign up to set email alerts
|

Mapping Daunorubicin-binding Sites in the ATP-binding Cassette Transporter MsbA Using Site-specific Quenching by Spin Labels

Abstract: ATP-binding cassette (ABC) transporters transduce the free energy of ATP hydrolysis to power the mechanical work of substrate translocation across cell membranes. MsbA is an ABC transporter implicated in trafficking lipid A across the inner membrane of Escherichia coli. It has sequence similarity and overlapping substrate specificity with multidrug ABC transporters that export cytotoxic molecules in humans and prokaryotes. Despite rapid advances in structure determination of ABC efflux transporters, little is … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
29
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 49 publications
2
29
0
Order By: Relevance
“…The cysteine-less BmrCD (BmrCD-WT*)(Mishra et al, 2014), cysteine-less MsbA (MsbA-WT*)(Dong et al, 2005; Smriti et al, 2009; Zou and McHaourab, 2009), hereafter referred to as BmrCD and MsbA, and their double cysteine mutants were purified by sequential nickel affinity and size-exclusion chromatography (SEC) as previously described. Double cysteine mutants of BmrCD and MsbA were incubated with a 20-fold excess of (1-Oxyl-2,2,5,5-tetramethylpyrroline-3-methyl) methanethiosulfonate (MTSSL, Enzo Life Sciences) for 4 h at 23 °C and placed on ice for ~12 h. The labeled proteins were then separated from free label by SEC on a Superdex 200 column equilibrated with respective SEC buffer.…”
Section: Methods Detailsmentioning
confidence: 99%
“…The cysteine-less BmrCD (BmrCD-WT*)(Mishra et al, 2014), cysteine-less MsbA (MsbA-WT*)(Dong et al, 2005; Smriti et al, 2009; Zou and McHaourab, 2009), hereafter referred to as BmrCD and MsbA, and their double cysteine mutants were purified by sequential nickel affinity and size-exclusion chromatography (SEC) as previously described. Double cysteine mutants of BmrCD and MsbA were incubated with a 20-fold excess of (1-Oxyl-2,2,5,5-tetramethylpyrroline-3-methyl) methanethiosulfonate (MTSSL, Enzo Life Sciences) for 4 h at 23 °C and placed on ice for ~12 h. The labeled proteins were then separated from free label by SEC on a Superdex 200 column equilibrated with respective SEC buffer.…”
Section: Methods Detailsmentioning
confidence: 99%
“…MsbA-WT* and cysteine substituted mutants were expressed, purified and labeled as previously described (Smriti et al, 2009; Zou and Mchaourab, 2009). …”
Section: Methodsmentioning
confidence: 99%
“…Fluorescence quenching was used to identify allocrites (reviewed in Ref. 6) and their putative binding sites (22,23). Infrared spectroscopy with detection of secondary structure, hydrogen/deuterium exchange rates, and linear dichroism have been used to determine orientation and accessibility profiles of helices in lipid bilayers, e.g.…”
Section: Msba Is An Essentialmentioning
confidence: 99%